Crat 6mg Tablet DEFLAZACORT
Introduction to Crat 6mg Tablet
The Crat 6mg Tablet is a medication primarily used to treat certain medical conditions by reducing inflammation and suppressing the immune system. It is especially beneficial for children aged 5 and older who are dealing with muscle weakening diseases.
Composition of Crat 6mg Tablet
The active ingredient in Crat 6mg Tablet is Deflazacort. This component is crucial for its effectiveness in managing inflammation and immune responses.
Uses of Crat 6mg Tablet
- Treatment of Duchenne muscular dystrophy (DMD) in children aged 5 and older.
- Reduction of inflammation in various conditions.
- Suppression of the immune system to prevent overactivity.
Side effects of Crat 6mg Tablet
Common side effects:
- Weight gain
- Increased appetite
- Round face (Cushingoid appearance)
- Upper respiratory infections (common cold)
- Frequent urination
- Nose and throat inflammation
- Excessive hair growth
- Irritability
Serious side effects:
- Allergic reactions such as rash, itching, or swelling
- Severe dizziness
- Trouble breathing
Precautions of Crat 6mg Tablet
Before taking Crat 6mg Tablet, inform your doctor if you are allergic to it or any of its ingredients. Use with caution during pregnancy and breastfeeding. Do not stop taking the medication suddenly, as it can lead to steroid withdrawal syndrome, causing symptoms like loss of appetite, nausea, vomiting, tiredness, and headache.
How to Take Crat 6mg Tablet
- Take the tablet once daily by mouth.
- The recommended dose is about 0.9 mg for each kilogram of body weight.
- It can be taken with or without food.
- Avoid taking it with grapefruit juice.
Conclusion of Crat 6mg Tablet
The Crat 6mg Tablet is an effective medication for managing inflammation and immune responses, particularly in children with Duchenne muscular dystrophy. However, it is important to follow the prescribed dosage and take necessary precautions to avoid potential side effects. Always consult with your healthcare provider for personalized advice and guidance.





